EN PL

EMA: Draft guideline on the evaluation of medicinal products for the treatment of chronic constipation

13.03.2014
This guideline intends to address the EU regulatory position in the main topics of clinical development of new medicinal products in the treatment of chronic constipation, opioid-induced constipation, and for the development of medicinal products intended for the cleansing of the bowels before medical procedures needing a “clean” bowel.